Insider · CIK 0001707715

Scadden David

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001707715

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,816 sh	—	—	20,419
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,816 sh	—	—	0
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,927 sh	—	—	2,927
2026-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15K sh	—	—	14,950
2026-06-17	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+51.7K sh	—	—	51,700
2025-11-12	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+200 sh	$18.09	+$3,618	17,803
2025-11-12	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$43.84	−$8,768	17,603
2025-11-12	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−200 sh	—	—	26,907
2025-10-08	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+200 sh	$18.09	+$3,618	17,803
2025-10-08	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$41.00	−$8,200	17,603
2025-10-08	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−200 sh	—	—	27,107
2025-09-30	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+200 sh	$18.09	+$3,618	17,803
2025-09-30	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$40.00	−$8,000	17,603
2025-09-30	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−200 sh	—	—	27,307
2025-08-27	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+200 sh	$18.09	+$3,618	17,803
2025-08-27	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$40.00	−$8,000	17,603
2025-08-27	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−200 sh	—	—	27,507
2025-07-10	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,400 sh	$18.09	+$25.3K	19,003
2025-07-10	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−1,400 sh	$40.00	−$56K	17,603
2025-07-10	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,400 sh	—	—	27,707
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+2,120 sh	—	—	17,603
2025-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−2,120 sh	—	—	0
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,816 sh	—	—	2,816
2025-06-18	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+15.8K sh	—	—	15,768
2025-06-06	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+37.5K sh	—	—	37,500
2024-12-11	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+200 sh	$18.09	+$3,618	15,683
2024-12-11	AGIOAGIOS PHARMACEUTICALS, INC.S Sale	Director	SSale	−200 sh	$46.28	−$9,256	15,483
2024-12-11	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)M Exercise/Conversion	Director	MExercise/Conversion	−200 sh	—	—	29,107
2024-07-01	CARMCarisma Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+38.7K sh	—	—	38,700
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+2,120 sh	—	—	2,120
2024-06-20	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+11.8K sh	—	—	11,774
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+3,388 sh	—	—	15,483
2024-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−3,388 sh	—	—	0
2024-05-30	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2023-06-21	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+4,975 sh	—	—	12,095
2023-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Director	MExercise/Conversion	−4,975 sh	—	—	0
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsA Award	Director	AAward	+3,388 sh	—	—	3,388
2023-06-13	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+19K sh	—	—	18,958
2023-06-01	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-06-28	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Director	AAward	+4,975 sh	—	—	4,975
2022-06-21	AGIOAGIOS PHARMACEUTICALS, INC. · Stock options (right to buy)A Award	Director	AAward	+29.3K sh	—	—	29,307
2022-06-09	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+25K sh	—	—	25,000
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,585 sh	—	—	7,120
2022-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitM Exercise/Conversion	Director	MExercise/Conversion	−1,585 sh	—	—	0
2021-06-03	EDITEditas Medicine, Inc. · Stock Option (right to buy)A Award	Director	AAward	+11.5K sh	—	—	11,538
2021-06-01	DNTHDianthus Therapeutics, Inc. /DE/ · Stock Option (Right to Buy)A Award	Director	AAward	+18.2K sh	—	—	18,188
2021-05-28	AGIOAGIOS PHARMACEUTICALS, INC.M Exercise/Conversion	Director	MExercise/Conversion	+1,686 sh	—	—	5,535
2021-05-28	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitsM Exercise/Conversion	Director	MExercise/Conversion	−1,686 sh	—	—	0
2021-05-20	AGIOAGIOS PHARMACEUTICALS, INC. · Restricted stock unitA Award	Director	AAward	+1,585 sh	—	—	1,585

Recent filings

Accepted (ET)
Jun 234
Scadden David0001439222-26-000095
SEC(opens sec.gov)
Jun 224
Scadden David0001650664-26-000069
SEC(opens sec.gov)
Nov 144
Scadden David0001439222-25-000120
SEC(opens sec.gov)
Oct 104
Scadden David0001439222-25-000108
SEC(opens sec.gov)
Oct 24
Scadden David0001439222-25-000106
SEC(opens sec.gov)
Aug 294
Scadden David0001439222-25-000100
SEC(opens sec.gov)
Jul 154
Scadden David0001439222-25-000084
SEC(opens sec.gov)

Companies

Address

C/O AGIOS PHARMACEUTICALS, INC. 88 SIDNEY STREET

CAMBRIDGE, MA, 02139